[go: up one dir, main page]

ZA200806095B - Means and methods for the treatment of tumorous diseases - Google Patents

Means and methods for the treatment of tumorous diseases

Info

Publication number
ZA200806095B
ZA200806095B ZA200806095A ZA200806095A ZA200806095B ZA 200806095 B ZA200806095 B ZA 200806095B ZA 200806095 A ZA200806095 A ZA 200806095A ZA 200806095 A ZA200806095 A ZA 200806095A ZA 200806095 B ZA200806095 B ZA 200806095B
Authority
ZA
South Africa
Prior art keywords
treatment
methods
tumorous diseases
tumorous
diseases
Prior art date
Application number
ZA200806095A
Inventor
Baeuerle Patrick
Kufer Peter
Klinger Matthias
Leo Eugen
Original Assignee
Micromet Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micromet Ag filed Critical Micromet Ag
Publication of ZA200806095B publication Critical patent/ZA200806095B/en

Links

ZA200806095A 2005-12-16 2008-07-14 Means and methods for the treatment of tumorous diseases ZA200806095B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05027606 2005-12-16

Publications (1)

Publication Number Publication Date
ZA200806095B true ZA200806095B (en) 2009-06-24

Family

ID=40206390

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200806095A ZA200806095B (en) 2005-12-16 2008-07-14 Means and methods for the treatment of tumorous diseases

Country Status (2)

Country Link
CN (1) CN101331151A (en)
ZA (1) ZA200806095B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2417065T3 (en) 2005-04-26 2013-08-05 Trion Pharma Gmbh Combination of antibodies with glucocorticoids for cancer treatment
SMT201900278T1 (en) * 2008-11-07 2019-07-11 Amgen Res Munich Gmbh Treatment of acute lymphoblastic leukemia
CA2774919C (en) * 2009-10-27 2022-03-08 Micromet Ag Dosage regimen for administering a cd19xcd3 bispecific antibody
CN103459425B (en) * 2010-10-27 2015-11-25 安进研发（慕尼黑）股份有限公司 Be used for the treatment of the composition of DLBCL
RS55995B2 (en) * 2010-11-10 2024-04-30 Amgen Res Munich Gmbh Prevention of adverse effects caused by cd3 specific binding domains
CN105017422A (en) * 2014-04-30 2015-11-04 山东百因制药技术有限公司 Anti-CD3/anti-CD19 dual-specific antibody and application thereof

Also Published As

Publication number Publication date
CN101331151A (en) 2008-12-24

Similar Documents

Publication Publication Date Title
PL1976886T3 (en) Means and methods for the treatment of tumorous diseases
IL227841A0 (en) Dihydropteridinones for the treatment of cancer diseases
EP1968607A4 (en) Treatment of cancer and other diseases
IL181305A0 (en) Combinations for the treatment of diseases involving cell proliferation
IL177490A0 (en) Methods for the treatment of tinnitus induced by cochlear excitotoxicity
EP1811844A4 (en) Methods for diagnosis and treatment of cancer
IL188204A0 (en) Combination therapy for the treatment of immunoinflammatory disorders
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
PT1881824E (en) Use of docosahexaenoic triglycerides for the treatment of tumorous diseases
PL1919290T3 (en) Methods and products for treatment of diseases
EP1812077A4 (en) Modulators of epha2 and ephrina1 for the treatment of fibrosis-related disease
ZA200806095B (en) Means and methods for the treatment of tumorous diseases
GB0523961D0 (en) The treatment of ophthalmic diseases
GB0426196D0 (en) Methods of treatment
IL191887A0 (en) Method for the diagnosis and treatment of cardiovascular diseases
IL185900A0 (en) Compositions and methods for the diagnosis and treatment of tumor
ZA200606780B (en) Compounds for the treatment of diseases
ZA200706159B (en) Compositions and methods for the diagnosis and treatment of tumor
GB0523964D0 (en) The treatment of ophthalmic diseases
EP1846013A4 (en) Treatment of skin diseases
GB0519274D0 (en) The treatment of neurodegenerative diseases
IL175611A0 (en) Combinations for the treatment of proliferative diseases
GB0408752D0 (en) Therapeutic treatment
GB0523965D0 (en) The treatment of ophthalmic diseases
GB0523962D0 (en) The treatment of ophthalmic diseases